Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma.
Shigehisa Kitano
No relevant relationships to disclose
Michael Andrew Postow
No relevant relationships to disclose
Czrina Cortez
No relevant relationships to disclose
Teresa Rasalan
No relevant relationships to disclose
Humilidad F. Gallardo
No relevant relationships to disclose
Katherine Panageas
No relevant relationships to disclose
Jianda Yuan
No relevant relationships to disclose
Jedd D. Wolchok
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Alexander M. Lesokhin
No relevant relationships to disclose